Cargando…

Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis

BACKGROUND: Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a key post-translational modification (PTM) in regulation of various cellular processes, and the sulfated adhesion molecules and chemokine receptors have...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Daopeng, Zhu, Zhengbin, Han, Hui, Xu, Tian, Feng, Shuo, Zhang, Wenli, Ding, Fenghua, Zhang, Ruiyan, Zhu, Jinzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332009/
https://www.ncbi.nlm.nih.gov/pubmed/37424015
http://dx.doi.org/10.1186/s12915-023-01641-y
_version_ 1785070354540003328
author Dai, Daopeng
Zhu, Zhengbin
Han, Hui
Xu, Tian
Feng, Shuo
Zhang, Wenli
Ding, Fenghua
Zhang, Ruiyan
Zhu, Jinzhou
author_facet Dai, Daopeng
Zhu, Zhengbin
Han, Hui
Xu, Tian
Feng, Shuo
Zhang, Wenli
Ding, Fenghua
Zhang, Ruiyan
Zhu, Jinzhou
author_sort Dai, Daopeng
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a key post-translational modification (PTM) in regulation of various cellular processes, and the sulfated adhesion molecules and chemokine receptors have been shown to participate in the pathogenesis of atherosclerosis via enhancement of monocyte/macrophage function. The levels of inorganic sulfate, the essential substrate for the sulfation reaction, are dramatically increased in patients with CKD, which indicates a change of sulfation status in CKD patients. Thus, in the present study, we detected the sulfation status in CKD patients and probed into the impact of sulfation on CKD-related atherosclerosis by targeting tyrosine sulfation function. RESULTS: PBMCs from individuals with CKD showed higher amounts of total sulfotyrosine and tyrosylprotein sulfotransferase (TPST) type 1 and 2 protein levels. The plasma level of O-sulfotyrosine, the metabolic end product of tyrosine sulfation, increased significantly in CKD patients. Statistically, O-sulfotyrosine and the coronary atherosclerosis severity SYNTAX score positively correlated. Mechanically, more sulfate-positive nucleated cells in peripheral blood and more abundant infiltration of sulfated macrophages in deteriorated vascular plaques in CKD ApoE null mice were noted. Knockout of TPST1 and TPST2 decreased atherosclerosis and peritoneal macrophage adherence and migration in CKD condition. The sulfation of the chemokine receptors, CCR2 and CCR5, was increased in PBMCs from CKD patients. CONCLUSIONS: CKD is associated with increased sulfation status. Increased sulfation contributes to monocyte/macrophage activation and might be involved in CKD-related atherosclerosis. Inhibition of sulfation may suppress CKD-related atherosclerosis and is worthy of further study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-023-01641-y.
format Online
Article
Text
id pubmed-10332009
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103320092023-07-11 Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis Dai, Daopeng Zhu, Zhengbin Han, Hui Xu, Tian Feng, Shuo Zhang, Wenli Ding, Fenghua Zhang, Ruiyan Zhu, Jinzhou BMC Biol Research Article BACKGROUND: Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a key post-translational modification (PTM) in regulation of various cellular processes, and the sulfated adhesion molecules and chemokine receptors have been shown to participate in the pathogenesis of atherosclerosis via enhancement of monocyte/macrophage function. The levels of inorganic sulfate, the essential substrate for the sulfation reaction, are dramatically increased in patients with CKD, which indicates a change of sulfation status in CKD patients. Thus, in the present study, we detected the sulfation status in CKD patients and probed into the impact of sulfation on CKD-related atherosclerosis by targeting tyrosine sulfation function. RESULTS: PBMCs from individuals with CKD showed higher amounts of total sulfotyrosine and tyrosylprotein sulfotransferase (TPST) type 1 and 2 protein levels. The plasma level of O-sulfotyrosine, the metabolic end product of tyrosine sulfation, increased significantly in CKD patients. Statistically, O-sulfotyrosine and the coronary atherosclerosis severity SYNTAX score positively correlated. Mechanically, more sulfate-positive nucleated cells in peripheral blood and more abundant infiltration of sulfated macrophages in deteriorated vascular plaques in CKD ApoE null mice were noted. Knockout of TPST1 and TPST2 decreased atherosclerosis and peritoneal macrophage adherence and migration in CKD condition. The sulfation of the chemokine receptors, CCR2 and CCR5, was increased in PBMCs from CKD patients. CONCLUSIONS: CKD is associated with increased sulfation status. Increased sulfation contributes to monocyte/macrophage activation and might be involved in CKD-related atherosclerosis. Inhibition of sulfation may suppress CKD-related atherosclerosis and is worthy of further study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-023-01641-y. BioMed Central 2023-07-10 /pmc/articles/PMC10332009/ /pubmed/37424015 http://dx.doi.org/10.1186/s12915-023-01641-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Dai, Daopeng
Zhu, Zhengbin
Han, Hui
Xu, Tian
Feng, Shuo
Zhang, Wenli
Ding, Fenghua
Zhang, Ruiyan
Zhu, Jinzhou
Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
title Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
title_full Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
title_fullStr Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
title_full_unstemmed Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
title_short Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
title_sort enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332009/
https://www.ncbi.nlm.nih.gov/pubmed/37424015
http://dx.doi.org/10.1186/s12915-023-01641-y
work_keys_str_mv AT daidaopeng enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis
AT zhuzhengbin enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis
AT hanhui enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis
AT xutian enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis
AT fengshuo enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis
AT zhangwenli enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis
AT dingfenghua enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis
AT zhangruiyan enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis
AT zhujinzhou enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis